3,3'-diaminobenzidine has been researched along with Leukemia, Myeloid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cardullo, Lde S; Catovsky, D; Morilla, R | 1 |
| Araki, M; Matsumura, K; Noriyasu, H; Okano, K; Yamamoto, K; Yonehara, Y | 1 |
2 other study(ies) available for 3,3'-diaminobenzidine and Leukemia, Myeloid
| Article | Year |
|---|---|
Significance of Phi bodies in acute leukaemia.
Topics: 3,3'-Diaminobenzidine; Bone Marrow; Histocytochemistry; Humans; Hydrogen-Ion Concentration; Inclusion Bodies; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Peroxidase | 1981 |
[The sensitivity and specificity of various peroxidase stains--the difference between DAB and 3AC stainings].
Topics: 3,3'-Diaminobenzidine; Carbazoles; Clinical Enzyme Tests; Humans; Leukemia, Myeloid; Microscopy, Electron; Peroxidase; Sensitivity and Specificity; Staining and Labeling | 1992 |